SCTL

Societal CDMO, Inc.

1.06 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Societal CDMO, Inc. stock is up 135.56% since 30 days ago. The next earnings date is Mar 19, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 20% of the previous 4 March’s closed higher than February. 0% of analysts rate it a buy.

About Societal CDMO, Inc.

Societal CDMO, Inc., a contract development and manufacturing organization, engages in the research and development, manufacturing, and packaging for various therapeutic dosage forms primarily in the small molecules in the United States and internationally. It provides therapeutic development, end-to-end regulatory support, clinical and commercial manufacturing, aseptic fill/finish, lyophilization, packaging and logistics services to the global pharmaceutical market. The company was formerly known as Recro Pharma, Inc. and changed its name to Societal CDMO, Inc. in March 2022. Societal CDMO, Inc. was incorporated in 2007 and is based in Exton, Pennsylvania.